Mode
Text Size
Log in / Sign up

Glucocorticoid use and rheumatoid arthritis significantly increase vertebral fracture risk in postmenopausal womenSeveral risk factors increase fracture risk for women with osteoporosis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that glucocorticoid use and rheumatoid arthritis are associated with significantly higher vertebral fracture risks.

This meta-analysis synthesized data from 11 studies involving 7,605 participants to identify risk factors for vertebral fractures among postmenopausal women. The analysis evaluated several clinical and demographic variables, including age, BMI, previous fracture history, lumbar-spine bone mineral density (BMD), glucocorticoid use, and rheumatoid arthritis.

The meta-analysis found that multiple factors are associated with an increased likelihood of vertebral fracture. Specifically, glucocorticoid use showed an OR of 2.34 (95% CI: 1.34 to 4.09). Rheumatoid arthritis was associated with a higher risk (OR = 2.99; 95% CI: 1.38 to 6.45). Other significant associations included previous fracture (OR = 1.78), low lumbar-spine BMD (OR = 1.55), advanced age (OR = 1.07), and higher BMI (OR = 1.07).

Clinical implications suggest that early screening and intervention are warranted for patients with high-risk profiles, including those over age 60, those with a history of fracture, or those using glucocorticoids. Because the underlying data are from observational studies, these results indicate associations rather than established causality.

How this fits prior evidence

This meta-analysis addresses a gap in identifying specific risk factors for vertebral fractures in postmenopausal women. It specifically highlights the role of rheumatoid arthritis and glucocorticoid use as significant risk factors. While previous coverage noted that JAK inhibitors show 81.7% treatment retention in patients with rheumatoid arthritis, this study provides evidence on the skeletal complications associated with the disease state.

Living with osteoporosis or rheumatoid arthritis can make your bones more fragile. New data from 11 studies involving over 7,600 women highlights specific factors that significantly increase the chance of suffering a vertebral fracture, which is a break in the bones of the spine.

The research shows that while age and a higher body mass index (BMI) are linked to more fractures, other factors carry even heavier risks. Specifically, having a previous fracture or low bone mineral density in the lower back increases the likelihood of a new break.

For women with rheumatoid arthritis or those using glucocorticoids (a type of steroid medication), the risk is notably higher. Because these findings come from observational studies, they show a link between these conditions and fractures rather than a direct cause. Talk to your doctor about these specific risks if you have these conditions.

What this means for you:
Rheumatoid arthritis and glucocorticoid use are linked to a much higher risk of spine fractures in women.

Common questions

Which conditions increase the risk of spine fractures?

The study found that several factors increase the risk of vertebral fractures. These include advanced age, a higher body mass index (BMI), and having a previous fracture. Additionally, low bone mineral density in the lower back, glucocorticoid use, and rheumatoid arthritis were all linked to a higher likelihood of a break.

How much does rheumatoid arthritis affect bone health?

The data shows that having rheumatoid arthritis is associated with a significantly higher risk of vertebral fractures. Specifically, the odds of a fracture were nearly three times higher for those with this condition compared to others in the study group.

Does using glucocorticoids increase my risk of a fracture?

Yes, the research indicates that glucocorticoid use is associated with a much higher likelihood of vertebral fractures. This finding suggests that patients on these medications may need extra monitoring for bone health and spine safety.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BackgroundVertebral fractures are the most common osteoporotic fractures in postmenopausal women and are strongly associated with higher morbidity, lower quality of life, and higher risk of death. Identifying risk factors for vertebral fractures in postmenopausal women is essential for early prevention and intervention. The aim of this study was to systematically assess and quantify the risk factors for vertebral fractures in postmenopausal women by meta-analysis.MethodsWe conducted a comprehensive search in PubMed, Embase, Web of Science, and Cochrane Library databases to include all observational studies reporting risk factors for vertebral fractures in postmenopausal women. The search was conducted from the date of database creation to April 20, 2025, Study screening, data extraction, and quality assessment were performed by two independent reviewers, and study quality was assessed using the Newcastle-Ottawa scale. Data were analyzed using Stata15 software.ResultsA total of 11 studies involving 7,605 participants were included. The meta-analysis showed that advanced age [odds ratio (OR) = 1.07, 95% confidence interval (CI): 1.03–1.12], higher body mass index (BMI; OR = 1.07, 95% CI: 1.01–1.14), previous fracture (OR = 1.78, 95% CI: 1.29–2.45), low lumbar-spine bone mineral density (BMD; OR = 1.55, 95% CI: 1.27–1.89), glucocorticoid use (OR = 2.34, 95% CI: 1.34–4.09), and rheumatoid arthritis (OR = 2.99, 95% CI: 1.38–6.45) were associated with a higher likelihood of vertebral fracture in postmenopausal women.ConclusionThis meta-analysis showed that risk factors for vertebral fracture in postmenopausal women include age over 60 years, higher body mass index, history of previous fracture, low lumbar bone density, glucocorticoid use, and rheumatoid arthritis. These factors significantly increase the risk of vertebral fractures. Therefore, early screening and intervention in these high-risk groups is warranted to reduce the incidence of vertebral fractures and to provide more individualized prevention and treatment strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.